`

Trillium Therapeutics Inc

Biotechnology Research

Sign Up to View More
revenue-icon Revenue
11M - 100M
funding-icon Total Funding
$130.0M
size-icon Size
11 - 50
About Us
Org Charts
Employees
Buyer Intent
Tech Stack
Jobs

Frequently Asked Questions About Trillium Therapeutics Inc

What does Trillium therapeutics inc do?+

Trillium Therapeutics Inc. (NASDAQ/TSX:TRIL) is a clinical stage immuno-oncology company developing innovative therapies for the treatment of cancer. We have a strong focus on CD47, a molecule that tumors frequently use to evade the immune system. CD47 is a protective do not eat signal that blocks the ability of certain immune cells to destroy the tumor. By blocking this do not eat signal with decoy receptors, we aim to unmask tumor cells and make them visible to, and eradicated by, the immune system

What is Trillium therapeutics inc's industry? +

Trillium therapeutics inc operates in the Biotechnology research industry.

What is Trillium therapeutics inc's revenue? +

Trillium therapeutics inc's revenue is 11m - 100m

What is Trillium therapeutics inc's company size? +

Trillium therapeutics inc has 11 - 50 employees.

The Go-to Sales Technology According to G2

G2 Badges Map
Get Started With Clodura
Sign Up

Sign Up for Free

Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.

Sign Up For Free
Supercharge Your Prospecting

Supercharge Your Prospecting

Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.

Sign Up For Free
Grow Your Business

Grow Your Business

Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.

Sign Up For Free